Literature DB >> 19476688

Cognitive behavioural therapy for major psychiatric disorder: does it really work? A meta-analytical review of well-controlled trials.

D Lynch1, K R Laws, P J McKenna.   

Abstract

BACKGROUND: Although cognitive behavioural therapy (CBT) is claimed to be effective in schizophrenia, major depression and bipolar disorder, there have been negative findings in well-conducted studies and meta-analyses have not fully considered the potential influence of blindness or the use of control interventions.
METHOD: We pooled data from published trials of CBT in schizophrenia, major depression and bipolar disorder that used controls for non-specific effects of intervention. Trials of effectiveness against relapse were also pooled, including those that compared CBT to treatment as usual (TAU). Blinding was examined as a moderating factor.
RESULTS: CBT was not effective in reducing symptoms in schizophrenia or in preventing relapse. CBT was effective in reducing symptoms in major depression, although the effect size was small, and in reducing relapse. CBT was ineffective in reducing relapse in bipolar disorder.
CONCLUSIONS: CBT is no better than non-specific control interventions in the treatment of schizophrenia and does not reduce relapse rates. It is effective in major depression but the size of the effect is small in treatment studies. On present evidence CBT is not an effective treatment strategy for prevention of relapse in bipolar disorder.

Entities:  

Mesh:

Year:  2009        PMID: 19476688     DOI: 10.1017/S003329170900590X

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  50 in total

Review 1.  Treatment for Negative Symptoms in Schizophrenia: A Comprehensive Review.

Authors:  Selene R T Veerman; Peter F J Schulte; Lieuwe de Haan
Journal:  Drugs       Date:  2017-09       Impact factor: 9.546

2.  Cognitive behavior therapy for people with schizophrenia.

Authors:  Ann K Morrison
Journal:  Psychiatry (Edgmont)       Date:  2009-12

3.  Prescribing antidepressants for depression: time to be dimensional and inclusive.

Authors:  Ian M Anderson; Peter M Haddad
Journal:  Br J Gen Pract       Date:  2011-01       Impact factor: 5.386

4.  The importance of cognitive processes for the integrative treatment of persons with schizophrenia.

Authors:  Mario Pfammatter; Hans Dieter Brenner; Ulrich Martin Junghan; Wolfgang Tschacher
Journal:  Schizophr Bull       Date:  2011-09       Impact factor: 9.306

5.  Psychological interventions to reduce positive symptoms in schizophrenia: systematic review and network meta-analysis.

Authors:  Irene Bighelli; Georgia Salanti; Maximilian Huhn; Johannes Schneider-Thoma; Marc Krause; Cornelia Reitmeir; Sofia Wallis; Felicitas Schwermann; Gabi Pitschel-Walz; Corrado Barbui; Toshi A Furukawa; Stefan Leucht
Journal:  World Psychiatry       Date:  2018-10       Impact factor: 49.548

Review 6.  Cognitive behavioral therapy for mood disorders: efficacy, moderators and mediators.

Authors:  Ellen Driessen; Steven D Hollon
Journal:  Psychiatr Clin North Am       Date:  2010-09

7.  Cognitive Behavioral Therapy for Psychosis (CBT-p) Delivered in a Community Mental Health Setting: A Case Comparison of Clients Receiving CBT Informed Strategies by Case Managers Prior to Therapy.

Authors:  Harry J Sivec; Vicki L Montesano; David Skubby; Kristen A Knepp; Mark R Munetz
Journal:  Community Ment Health J       Date:  2015-08-23

Review 8.  A Meta-Analysis of Social Skills Training and Related Interventions for Psychosis.

Authors:  David T Turner; Edel McGlanaghy; Pim Cuijpers; Mark van der Gaag; Eirini Karyotaki; Angus MacBeth
Journal:  Schizophr Bull       Date:  2018-04-06       Impact factor: 9.306

Review 9.  A systematic review of the combined use of electroconvulsive therapy and psychotherapy for depression.

Authors:  Shawn M McClintock; Anna R Brandon; Mustafa M Husain; Robin B Jarrett
Journal:  J ECT       Date:  2011-09       Impact factor: 3.635

10.  Effectiveness of Family Intervention for Preventing Relapse in First-Episode Psychosis Until 24 Months of Follow-up: A Systematic Review With Meta-analysis of Randomized Controlled Trials.

Authors:  Miguel Camacho-Gomez; Pere Castellvi
Journal:  Schizophr Bull       Date:  2020-01-04       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.